Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Accepts healthy volunteers

Wireless Innovation for Seniors With Diabetes Mellitus

ClinicalTrials.gov ID: NCT03240432

Public ClinicalTrials.gov record NCT03240432. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 3:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Wireless Innovation for Seniors With Diabetes Mellitus (WISDM)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the study is to determine if CGM can reduce hypoglycemia and improve quality of life in older adults with T1D.

Study identification

NCT ID
NCT03240432
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Enrollment
200 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
60 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 25, 2017
Primary completion
Jun 5, 2019
Completion
Sep 9, 2019
Last update posted
Sep 11, 2019

2017 – 2019

United States locations

U.S. sites
22
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
University of Southern California Beverly Hills California 90211
Scripps Whittier Diabetes Institute La Jolla California 92037
University of Colorado - Barbara Davis Center Aurora Colorado 80045
University of Miami Miami Florida 33136
Florida Hospital Diabetes Institute Orlando Florida 32804
Atlanta Diabetes Associates Atlanta Georgia 30318
Northwestern University Chicago Illinois 60611
University of Chicago Chicago Illinois 60637
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265
University of Massachusetts Worcester Massachusetts 01655
University of Michigan Ann Arbor Michigan 48105
Henry Ford Health System Detroit Michigan 48202
International Diabetes Center Minneapolis Minnesota 55416
Mayo Clinic Rochester Minnesota 55905
Washington University St Louis Missouri 63110
Icahn School of Medicine at Mount Sinai New York New York 10029
Columbia University - Naomi Berrie Diabetes Center New York New York 10032
SUNY Upstate Medical University Syracuse New York 13210
University of North Carolina Chapel Hill North Carolina 27517
Oregon Health & Science University Portland Oregon 97239
University of Pennsylvania Philadelphia Pennsylvania 19104
University of Washington Diabetes Care Center Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03240432, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 11, 2019 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03240432 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →